Abstract: This invention relates to the use of triorganophosphine compounds as catalyst for the reaction of phenols or thiophenols with cyclic organic carbonates.
Abstract: A method is provided for making certain hydroxy-terminated arylene ethers useful as spacers in liquid crystalline polyesters. There is initially formed a dicarbonyl adduct from a dihydroxyaromatic compound, such as hydroquinone and a haloarylcarbonyl compound. The adduct formed is oxidized to the corresponding diester. Hydrolysis of the diester provides the hydroxy-terminated arylene ether.
Abstract: A hemoglobin-containing blood substitute preparation is protected from oxtion to methemoglobin. The protected preparation comprises between 10 mM and 60 mM of a compound selected from the group consisting of glutathione (GSH), nicotinamide adenine dinucleotide (NADH), nicotine adenine dinucleotide phosphate (NADPH) and mixtures of these in the aqueous phase of a hemoglobin-containing fluid. Oxidized hemoglobin in a preparation can be restored by adding between 10 mM and 60 mM of a compound selected from the group consisting of glutathione (GSH), nicotinamide adenine dinucleotide (NADH), nicotine adenine dinucleotide phosphate (NADPH) and mixtures of these to a hemoglobin-containing fluid in which the hemoglobin has converted in whole or part to methemoglobin, and storing the fluid at storage temperatures for blood products above the freezing point of the fluid for a time sufficient to convert methemoglobin to hemoglobin.
Type:
Grant
Filed:
August 9, 1988
Date of Patent:
September 24, 1991
Assignee:
The United States of America as represented by the Secretary of the Navy
Inventors:
Lewis P. Stratton, Martha C. Farmer, Alan S. Rudolph
Abstract: The present invention relates to a group of compounds which are novel squalene derivatives containing the cyclopropyloxy functionality and which act to inhibit the synthesis of cholesterol in mammals and in fungi.
Type:
Grant
Filed:
March 22, 1990
Date of Patent:
September 24, 1991
Assignee:
Merrell Dow Pharmaceuticals Inc.
Inventors:
Michael R. Angelastro, Norton P. Peet, Philippe Bey
Abstract: This invention encompasses a compound of the formula: ##STR1## wherein: R.sub.1 and R.sub.2 are the same or different members of the group consisting of 1,1-dimethylethyl, halo, phenyl and substituted phenyl; Alk is straight or branched chain lower alkylene; R.sub.4 is hydrogen or lower alkyl; R.sub.3 is hydrogen or lower alkyl; or a cycloalkyl group of from 3 to 8 carbon atoms. The formulation of this invention are useful as anti-inflammatory and anti-allergy agents.
Abstract: Purified L-quebrachitol is recovered in increased quantities from rubber latex by dissolving concentrated solutions or pulverized solids of the serums in methyl alcohol under specified extraction conditions.
Type:
Grant
Filed:
June 28, 1989
Date of Patent:
August 20, 1991
Assignees:
The Yokohama Rubber Co., Ltd., The Board of the Rubber Research Institute of Malaysia
Abstract: A process for the preparation of aralkyl hydroperoxides having the formula (I) is described ##STR1## in which n=1, 2 or 3, Ar means a phenyl group which can be substituted with halogen or one or more branched or straight chain alkyl groups with 1 to 5 C-atoms, or a naphthyl group, and each radical R.sup.1 and R.sup.2 means a low alkyl radical, the alkyl radicals R.sup.1 and R.sup.2 together having 2 to 4 carbon atoms, by reaction of aralkyl carbinols having the formula (II) ##STR2## in which Ar, R.sup.1, R.sup.2 and n have the meaning given for formula (I), with hydrogen peroxide under acid conditions, the reaction being carried out in the presence of an acid-combining agent. An alkali sulphate, ammonium sulphate, alkali hydrogen sulphate and/or ammonium hydrogen sulphate is used in preference as the acid-combining agent. Tert.aralkyl hydroperoxides can be prepared in high yield with a high purity in a simple and safe manner with this process.
Type:
Grant
Filed:
November 7, 1989
Date of Patent:
July 16, 1991
Assignee:
Peroxid-Chemie GmbH
Inventors:
Maximilian Dorn, Eberhard Hagel, Werner Zeiss
Abstract: A formylated alkylbenzenesulfonyl halide compound represented by the following general formula (I): ##STR1## wherein R.sub.1 is an alkyl group having 1 to 5 carbon atoms; R.sub.2 and R.sub.3 are each a member selected from the group consisting of a hydrogen atom and alkyl groups having 1 to 5 carbon atoms; X is a halogen atom; the sulfonyl halide group is present at the ortho or para position while the formyl group at the para or ortho position relative to the group R.sub.1 when R.sub.2 and R.sub.3 are both a hydrogen atom, while the sulfonyl halide group and the formyl group are present at the para positions relative to the groups R.sub.1 and R.sub.2, respectively, when R.sub.2 is an alkyl group and R.sub.3 is a hydrogen atom, or the sulfonylhalide group and the formyl group are present at the para positions relative to the groups R.sub.1 and R.sub.2, respectively, when R.sub.2 and R.sub.
Type:
Grant
Filed:
July 25, 1989
Date of Patent:
July 9, 1991
Assignee:
Agency of Industrial Science and Technology
Abstract: This invention relates to fluorinated vinyl ethers having the formula ##STR1## wherein t has a value of from 1 to 22; R' is C.sub.2 to C.sub.20 alkylene, alkoxyalkylene, arylene or aryloxyalkylene which radicals are optionally fluorinated; R" is a divalent radical having from 1 to 100 carbon atoms and is selected from the group of alkylene, arylene, alkarylene, aralkylene which groups are optionally substituted with lower alkyl or the radical ##STR2## wherein R is a polyvalent linear, branched or cyclic hydrocarbon radical having from 2 to 20 carbon atoms, optionally substituted with alkyleneoxy; A is a divalent radical selected from the group of ##STR3## where each of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 is independently hydrogen or ##STR4## B is lower alkyl; m has a value of from 0 to 4 and n has a value of from 0 to 20. The invention also relates to the manner of synthesizing the present fluorinated vinyl ethers and to their uses as release agents and stain protective coatings.
Abstract: A method of reducing or eliminating adverse effects of a pharmaceutical composition or a drug is disclosed. The method comprises administering to an animal or a human an amount of at least one specific isomer of inositol triphosphate sufficient to reduce or eliminate said adverse effects.
Abstract: A process for preparing 2-chloroterephthaloyl chloride which comprises reacting terephthaloyl chloride with chlorine in the presence of an anhydrous ring chlorination catalyst. When the reaction mixture contains the desired amount of the monochloro product, the mixture is cooled to room temperature and the 2-chloroterephthaloyl chloride is isolated.
Abstract: An oligohexafluoropropylene oxide compound having the general formula (I): ##STR1## wherein n represents an integer of 2 to 5. The compound is useful for preparing a polymer having good thermal resistance, chemical stability, non-adhesion properties, water and oil repellencies, and flexibility, when copolymerized if other monomers.
Abstract: Novel dipropargyl ether of alpha, alpha'-bis(4-hydroxyphenyl)-para-diisopropylbenzene is useful in preparing resins having desirable properties as laminates and the like.